Passage Bio Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Passage Bio Inc
CIK #0001787297
EDGAR Form CIK 2011 - 2026
10-K [0001787297]
10-Q [0001787297]
3 [0001787297]
4 [0001787297]
8-K [0001787297]
D [0001787297]
SC 13D [0001787297]
SC 13G [0001787297]
Form 13D/13G Filer Form 13D/13G Subject Filed
Lynx1 Capital Management LP Passage Bio Inc [2026-07-02]
Baselake Partners LP Passage Bio Inc [2026-06-25]
Vestal Point Capital LP Passage Bio Inc [2024-11-14]
Erste Asset Management GmbH Passage Bio Inc [2024-11-14]
Lynx1 Capital Management LP Passage Bio Inc [2024-03-29]
Lynx1 Capital Management LP Passage Bio Inc [2022-09-29]
BlackRock Inc Passage Bio Inc [2022-07-08]
BlackRock Inc Passage Bio Inc [2022-02-04]
Deep Track Capital LP Passage Bio Inc [2021-10-25]
New Leaf Ventures III LP Passage Bio Inc [2021-02-11]
View All
Form 3/4/5 Subject 2011 - 2026
Nichols Weston
Passage Bio Inc
Lynx1 Capital Management LP
Countouriotis Athena
Kapadia Sandip
Kassberg Thomas Richard
Porter Derrell
Gowen Maxine
Sondhi Dolan
Borthwick Kathleen
Chou William
OrbiMed Advisors LLC
OrbiMed Capital GP VII LLC
Islam Saqib
Cale Edgar B
Forman Mark S
King Simona
Fotopoulos Alexandros
Woiwode Thomas
Kamarck Michael E
Toernsen Monika Maria
Goldsmith Bruce A
Salinas Eliseo Oreste
Quigley Jill M
Burkavage Brian
Yamada Tadataka
Ratcliffe Liam
Morris Richard Steven
Romano Gary
Versant Vantage I LP
Versant Vantage I GP-GP LLC
Versant Ventures VI GP LP
Versant Vantage I GP LP
Versant Ventures VI GP-GP LLC
Versant Venture Capital VI LP
Frazier Life Sciences IX LP
Fhmls IX LLC
Topper James N
Fhmls IX LP
Heron Patrick J
Squinto Stephen P
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Passage Bio Inc PASG
Employee Stock Option (right to buy) · derivative
2026-03-16 Grant 15,610 $0.00
Passage Bio Inc PASG
Employee Stock Option (right to buy) · derivative
2026-03-16 Grant 58,000 $0.00
Passage Bio Inc PASG
Common Stock
2026-01-08 Option exercise 10,000
Passage Bio Inc PASG
Common Stock
2026-01-08 Option exercise 5,000
Passage Bio Inc PASG
Restricted Stock Unit · derivative
2026-01-08 Option exercise 10,000 $0.00
Passage Bio Inc PASG
Common Stock
2026-01-08 Sell 2,062 $18.44 38,023
Passage Bio Inc PASG
Restricted Stock Unit · derivative
2026-01-08 Option exercise 5,000 $0.00
Passage Bio Inc PASG
Common Stock
2026-01-08 Sell 4,076 $18.44 75,161
Passage Bio Inc PASG
Common Stock
2025-07-24 Buy 66,423 $5.71 379,275
Passage Bio Inc PASG
Common Stock
2025-07-23 Buy 49,302 $5.74 282,993
Passage Bio Inc PASG
"Common stock, $0.0001 par value per share (""Common Stock"")"
2025-07-22 Buy 13,123 $5.44 71,389
Passage Bio Inc PASG
Common Stock
2025-06-26 Sell 213,257 $0.33 70,375
Passage Bio Inc PASG
Common Stock
2025-06-25 Sell 138,800 $0.33 45,804
Passage Bio Inc PASG
Common Stock
2025-06-24 Sell 231,600 $0.35 81,060
Passage Bio Inc PASG
Director Stock Option (right to buy) · derivative
2025-05-28 Grant 201,857 $0.00
Passage Bio Inc PASG
Director Stock Option (right to buy) · derivative
2025-05-28 Grant 143,789 $0.00
Passage Bio Inc PASG
Director Stock Option (right to buy) · derivative
2025-05-28 Grant 201,857 $0.00
Passage Bio Inc PASG
Director Stock Option (right to buy) · derivative
2025-05-28 Grant 201,857 $0.00
Passage Bio Inc PASG
Director Stock Option (right to buy) · derivative
2025-05-28 Grant 201,857 $0.00
Passage Bio Inc PASG
Director Stock Option (right to buy) · derivative
2025-05-28 Grant 201,857 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com